Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 499 | 0 | 104 | 13 |
| Inventories | 14 | 14 | 13 | N/A | N/A |
| TOTAL | $66 | $566 | $31 | $129 | $47 |
| Non-Current Assets | |||||
| PPE Net | 41 | 50 | 59 | 69 | 79 |
| Intangibles | 1,143 | 1,160 | 1,177 | 1,195 | 1,212 |
| Other Non-Current Assets | 0 | 0 | 0 | 4 | 4 |
| TOTAL | $1,184 | $1,210 | $1,237 | $1,268 | $1,295 |
| Total Assets | $1,250 | $1,776 | $1,268 | $1,398 | $1,342 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,003 | 773 | 771 | 700 | 440 |
| Accrued Expenses | 1,372 | 1,348 | 1,083 | 1,107 | 839 |
| Other current liabilities | N/A | N/A | N/A | 26 | N/A |
| TOTAL | $3,354 | $3,059 | $2,816 | $6,475 | $5,600 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,632 | 3,555 | 3,594 | N/A | N/A |
| TOTAL | $3,632 | $3,555 | $3,594 | $N/A | $N/A |
| Total Liabilities | $6,986 | $6,614 | $6,410 | $6,475 | $5,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5 | 5 | 246 | 217 | 205 |
| Common Shares | 17 | 17 | 15 | 718 | 701 |
| Retained earnings | -16,878 | -15,627 | -14,061 | -12,142 | -10,665 |
| Other shareholders' equity | -32 | -32 | -32 | -32 | -32 |
| TOTAL | $-5,736 | $-4,838 | $-5,142 | $-5,078 | $-4,258 |
| Total Liabilities And Equity | $1,250 | $1,776 | $1,268 | $1,397 | $1,342 |